Tech Company Financing Transactions
Promise Bio Funding Round
Promise Bio, based in Tel Aviv, raised $8.3 million from Awz Ventures, AstraZeneca and Israel Innovation Authority.
Transaction Overview
Company Name
Announced On
12/16/2024
Transaction Type
Venture Equity
Amount
$8,300,000
Round
Seed
Investors
Proceeds Purpose
The company intends to use the funds to accelerate the development of its computational platform, which uses epiproteomics and artificial intelligence to predict patient treatment responses and support drug research and development.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
Undisclosed
Tel Aviv, Undisclosed
Israel
Tel Aviv, Undisclosed
Israel
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Promise Bio, a Tel Aviv, Israel-based startup advancing immune-mediated disease treatment with precision medicine solutions.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Ronel Veksler
Chief Technical Officer
Assaf Kacen
Browse more venture capital transactions:
Prev: 12/16/2024: Xcoub venture capital transaction
Next: 12/16/2024: Radar venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs